Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population. | Int J Occup Med Environ Health | 2023 | 38099560 | PubTator, text mining | PubMed |
| MLLT11 siRNA Inhibits the Migration and Promotes the Apoptosis of MDA-MB-231 Breast Cancer Cells. | Breast J | 2023 | 38075552 | PubTator, text mining | PubMed |
| Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives. | Int J Mol Sci | 2023 | 38069210 | PubTator, text mining | PubMed |
| Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions. | Cell Biosci | 2023 | 38041134 | PubTator, text mining | PubMed |
| Human N-acetyltransferase 2 (NAT2) gene variability in Brazilian populations from different geographical areas. | Front Pharmacol | 2023 | 38035025 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. | Oncol Rev | 2023 | 38025894 | PubTator, text mining | PubMed |
| RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2023 | 38017479 | PubTator, text mining | PubMed |
| A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy. | Pharmaceutics | 2023 | 38004602 | PubTator, text mining | PubMed |
| Alternative Transcripts Diversify Genome Function for Phenome Relevance to Health and Diseases. | Genes (Basel) | 2023 | 38002994 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer. | BMC Med Genomics | 2023 | 37996875 | PubTator, text mining | PubMed |
| Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. | J Transl Med | 2023 | 37978542 | PubTator, text mining | PubMed |
| NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA. | Cancer Biol Ther | 2023 | 37948132 | PubTator, text mining | PubMed |
| Isoform switching leads to downregulation of cytokine producing genes in estrogen receptor positive breast cancer. | Front Genet | 2023 | 37900178 | PubTator, text mining | PubMed |
| Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer. | NPJ Breast Cancer | 2023 | 37857634 | PubTator, text mining | PubMed |
| The Physiological and Pathological Role of Acyl-CoA Oxidation. | Int J Mol Sci | 2023 | 37834305 | PubTator, text mining | PubMed |
| THE SCALABLE BIRTH-DEATH MCMC ALGORITHM FOR MIXED GRAPHICAL MODEL LEARNING WITH APPLICATION TO GENOMIC DATA INTEGRATION. | Ann Appl Stat | 2023 | 37830084 | PubTator, text mining | PubMed |
| Wood cookstove use is associated with gastric cancer in Central America and mediated by host genetics. | Sci Rep | 2023 | 37783717 | PubTator, text mining | PubMed |
| Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants. | Int J Mol Sci | 2023 | 37686209 | PubTator, text mining | PubMed |
| Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers. | Int J Mol Sci | 2023 | 37685859 | PubTator, text mining | PubMed |
| Exosome-Based Drug Delivery: Translation from Bench to Clinic. | Pharmaceutics | 2023 | 37631256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=4